Indication

Cerebral palsy-associated limb spasticity

Cerebral palsy-associated limb spasticity is a motor disorder characterized by velocity-dependent hypertonia and exaggerated tendon reflexes affecting the upper or lower extremities. Read more about Cerebral palsy-associated limb spasticity

6 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common Cerebral palsy-associated limb spasticity therapies.

Showing 1–6 of 6 drugs

Filter & compare in the drug finder →Opens the drug finder with Cerebral palsy-associated limb spasticity preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Cerebral palsy-associated limb spasticity.

Cerebral palsy-associated limb spasticity is a motor disorder characterized by velocity-dependent hypertonia and exaggerated tendon reflexes affecting the upper or lower extremities.

It is a manifestation of upper motor neuron syndrome arising from nonprogressive damage or malformation in the developing fetal or infant brain, which disrupts descending corticospinal pathways and causes an imbalance of supraspinal inhibitory and excitatory signaling.

This sustained muscular overactivity leads to restricted active and passive range of motion, abnormal postures, pain, and impaired gross or fine motor function.

Over time, persistent spasticity often produces secondary musculoskeletal complications, including progressive muscle stiffness, tendon shortening, joint contractures, and skeletal deformities.

Personalize your experience

Follow Cerebral palsy-associated limb spasticity and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it